|
HS Code |
898740 |
| Chemical Formula | C9H9NO2S |
| Molecular Weight | 195.24 |
| Appearance | Solid (Typical appearance) |
| Boiling Point | Data may vary, needs experimental determination |
| Melting Point | Data may vary, needs experimental determination |
| Solubility | Solubility characteristics depend on solvents |
| Density | Data may vary, needs experimental determination |
| Flash Point | Data may vary, needs experimental determination |
| Refractive Index | Data may vary, needs experimental determination |
| Pka | Data may vary, needs experimental determination |
As an accredited Ethyl 4H-Thieno[2,3-D]Pyrrole-5-Carboxylate factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | 100g of Ethyl 4H - Thieno[2,3 - D]Pyrrole - 5 - Carboxylate in sealed chemical - grade packaging. |
| Shipping | Ethyl 4H - Thieno[2,3 - D]Pyrrole - 5 - Carboxylate is shipped in well - sealed, corrosion - resistant containers. Packaging adheres to chemical safety regulations. Shipment is via approved carriers with proper handling to prevent damage and ensure safe transport. |
| Storage | Ethyl 4H - Thieno[2,3 - D]Pyrrole - 5 - Carboxylate should be stored in a cool, dry place away from direct sunlight. Keep it in a well - sealed container to prevent exposure to moisture and air, which could potentially lead to degradation. Store it separately from incompatible substances, such as strong oxidizing agents or acids, in a dedicated chemical storage area with proper ventilation. |
In the production workflow for an ATP-competitive kinase inhibitor candidate evaluated in a phase I/II solid tumor protocol, ethyl 4H-thieno[2,3-d]pyrrole-5-carboxylate is designated as the key starting material (KSM) per the ICH Q11 decision tree, with a defined criticality stemming from the fused thienopyrrole pharmacophore. The regulatory envelope governing its handling includes ICH Q7 (active pharmaceutical ingredient GMP), ICH M7 (DNA-reactive impurities, Option 3 control strategy), ICH Q3D (elemental impurities: Pd ≤ 10 ppm, Cu ≤ 300 ppm), 21 CFR 210/211, EU GMP Annex 11 for computerized batch records, and REACH (EC) 1907/2006 for registration of the substance at volumes exceeding 1 metric ton/year. The compound is typically introduced into the synthesis following electrophilic bromination at the electron-rich C2 position of the 4H-thieno[2,3-d]pyrrole ring, itself conducted in a glass-lined reactor at 0 °C to +5 °C using recrystallized N-bromosuccinimide (1.02 eq) in anhydrous DMF, with residual succinimide controlled via aqueous workup. The subsequent Suzuki–Miyaura coupling deploys the 2-bromo intermediate with a tailored aryl boronic acid pinacol ester; the stoichiometric ratio of the bromothienopyrrole ester to the boronate is maintained at 1.00:1.05, catalyzed by Pd(PPh₃)₄ at a loading of 0.005 eq, with 2 M aqueous K₂CO₃ (3 eq) in degassed 1,4-dioxane at 85 °C for 18 h under a nitrogen blanket (O₂ ≤ 50 ppm in headspace). Coupling conversion is tracked by inline HPLC (C18 column, UV 254 nm) with an acceptance threshold of ≤2.0 area% residual bromo intermediate before phase transfer.The downstream sequence proceeds through ester hydrolysis with LiOH·H₂O (1.5 eq) in THF/water (3:1 v/v) at 25 °C for 4 h, followed by acidification to isolate the free carboxylic acid as an off-white solid in yields typically exceeding 92% after belt-filter drying. Amide bond formation with a proprietary aniline fragment employs HATU (1.10 eq) and DIPEA (3.0 eq) in DMF at 0 °C to ambient, with an IPC limit of ≤0.5% residual acid per HPLC. Where the aniline moiety bears a Boc-protected piperazine, acidic deprotection in HCl/dioxane (4 M, 20 °C, 2 h) releases the active chemotype. Final purification by preparative reversed-phase HPLC (C18, acetonitrile/water + 0.1% TFA) and lyophilization delivers the API candidate as a di-TFA salt with chromatographic purity ≥99.7 area% and single unknown impurity ≤0.10%. The terminal dosage form is an orally administered tyrosine kinase inhibitor targeting a resistant EGFR mutation (L858R/T790M) in non-small-cell lung cancer; the active moiety incorporates the thieno[2,3-d]pyrrole scaffold as a hinge-binding adenine isostere. The following impurity control table is extracted from the API release specification directly aligned with ICH thresholds:
How Does Thienopyrrole Donor Architecture Optimize Voc in Polymer Solar Cells?When the ethyl ester substituent remains intact on the 4H-thieno[2,3-d]pyrrole ring, it imparts a moderate electron-withdrawing effect that deepens the HOMO energy level of the resulting donor–acceptor copolymer by approximately 0.15–0.25 eV relative to the unsubstituted analogue, thereby increasing open-circuit voltage in bulk heterojunction devices. Regulatory compliance for the electronic-grade monomer is framed not as a pharmaceutical standard but through RoHS Directive 2011/65/EU (restriction of Pb, Hg, Cd), REACH SVHC candidate list screening, and typical semiconductor-grade purity metrics adapted from SEMI PV guidelines: individual metal ion content (Na, K, Fe, Cu) is controlled to ≤50 ppb by ICP-MS, with total organic volatiles below 0.05 wt% per thermogravimetric analysis. The monomer is copolymerized via direct heteroarylation polymerization (DHAP) to avoid toxic organostannane byproducts, with a feed ratio of the 2-bromo-thienopyrrole ester to 4,7-dibromo-2,1,3-benzothiadiazole of 1.0:1.0, yielding a strictly alternating copolymer. The reaction runs in anhydrous DMAc with Pd₂(dba)₃ (2 mol%), PivOH (30 mol%), and K₂CO₃ (2.5 eq) at 100 °C for 72 h under argon, producing number-average molecular weights (Mn) in the 28–45 kDa range and dispersities Đ ≤2.2 by high-temperature GPC (1,2,4-trichlorobenzene, 150 °C, polystyrene calibration). After precipitation into methanol and sequential Soxhlet extraction (acetone, hexane, chloroform), the chloroform fraction is concentrated to a 10 mg/mL solution and spin-coated onto ITO/PEDOT:PSS in a N₂-filled glovebox (<1 ppm O₂/H₂O) to produce an active layer thickness of 100 nm. When blended with the non-fullerene acceptor Y6 at a 1:1.2 w/w ratio and cast from chloroform with 0.5 vol% 1-chloronaphthalene additive, the inverted architecture glass/ITO/ZnO/active/MoO₃/Ag delivers power conversion efficiencies measured under AM1.5G illumination (100 mW/cm², IEC 60904-3 Class AAA solar simulator, calibrated with a KG5 filtered Si reference cell). Final device modules are encapsulated with a UV-curable epoxy edge seal (60 °C cure, 15 min) and targeted for semi-transparent building-integrated photovoltaics.In bottom-gate bottom-contact organic field-effect transistor fabrication on heavily doped Si (gate) with 300 nm thermally grown SiO₂ dielectric (Ci 11.5 nF/cm²), the thieno[2,3-d]pyrrole-5-carboxylate scaffold is employed as a donor monomer copolymerized with a strong acceptor to suppress excessive crystallinity and maintain solution processability. Compliance follows IEEE 1620-2008 test methods for the characterization of organic transistors, surface resistivity per ASTM D257, and substrate cleaning protocols adapted from SEMI PV17-0612. The dielectric surface is treated with octadecyltrichlorosilane (OTS) by immersion in a 5 mM toluene solution for 2 h at 60 °C, yielding a water contact angle of ≥105°. Polymer semiconductors are synthesized by Stille cross-coupling between the bis-stannylated thienopyrrole ester and a dibrominated diketopyrrolopyrrole (DPP) acceptor, using a molar surplus of the acceptor to cap α‑bromo chain ends and suppress trapping; the donor:acceptor feed ratio is intentionally set to 28:72 mol% to disrupt long-range order and enhance charge transport isotropy. The resulting copolymer (Mn 18–35 kDa, Đ 1.8–2.5) is dissolved in anhydrous 1,2-dichlorobenzene at 5 mg/mL and deposited by solution shearing with a blade gap of 100 µm, substrate temperature 65 °C, and shearing speed 0.5 mm/s, yielding aligned films that are subsequently annealed under vacuum (10⁻⁶ mbar) at 120 °C for 30 min. Electrical characterization in a probe station (dark, ambient) extracts saturation-regime hole mobilities using the gradual channel approximation per ASTM F2662-08, and transfer curve hysteresis is quantified by the difference between forward and reverse sweeps (ΔVth). The table below collates representative parameter windows from a process development matrix:
Sensitizer Donor Modules for Iodolyte-Based DSSCsIn liquid-junction dye-sensitized solar cells designed for indoor energy harvesting under 200–1000 lux fluorescent illumination, ethyl 4H-thieno[2,3-d]pyrrole-5-carboxylate constitutes the electron-rich donor segment of a D–π–A sensitizer, with its ester moiety providing a convenient synthetic handle for titration of the LUMO level without disrupting the planar conjugated core. Deployment in a photovoltaic device compels adherence to IEC 60904-1 (measurement of P‑V characteristics), spectral responsivity evaluated per IEC 60904-8, and accelerated photoaging under ISO 4892-2 Xenon arc (0.51 W/m² at 340 nm, black panel 65 °C, 1000 h). The sensitizer molecule is assembled by Knoevenagel condensation of the aldehyde-terminated π‑bridge with cyanoacetic acid; the thienopyrrole donor fragment represents 42 wt% of the final molecular weight and its presence raises the molar extinction coefficient (ε) at the Soret band to ≥35,000 M⁻¹cm⁻¹. Sensitization baths are prepared at a concentration of 0.3 mM in acetonitrile/tert-butanol (1:1 v/v) with 10 mM chenodeoxycholic acid as a co-adsorbent, into which a screen-printed TiO₂ photoanode (active layer 10 µm thick, Transparent P25 paste, 450 °C sintering for 30 min, followed by TiCl₄ post-treatment at 70 °C for 30 min) is immersed in the dark for 18 h at 25 °C. The counter electrode is a platinized FTO glass (thermal decomposition of H₂PtCl₆·6H₂O at 400 °C), and the gap is filled with a volatile iodolyte based on 1-ethyl-3-methylimidazolium iodide/iodine/tert-butylpyridine in 3-methoxypropionitrile. Sealed cells yield stabilized power output suitable for trickle charging of wireless sensor node batteries in building automation; long-term dark storage stability at 85 °C for 1000 h retains ≥90% of initial PCE, provided the sensitizer ester does not hydrolyze due to residual moisture exceeding 20 ppm in the electrolyte filling.A method for detecting intracellular hydrogen peroxide in live-cell imaging uses a fluorescent probe built upon the ethyl 4H-thieno[2,3-d]pyrrole-5-carboxylate chromophore, where the electron-rich bicyclic unit acts as a push-pull fluorophore after functionalization at C2 and conversion of the C5 ester into a caspase-directing warhead. The analytical chemistry framework references USP 〈1225〉 for method validation of fluorometric assays and ISO 15189 for quality and competence in medical testing when deployed as an in vitro diagnostic research tool. The probe stock solution is prepared in anhydrous DMSO at 10 mM, then diluted into Hank’s Balanced Salt Solution (HBSS, pH 7.4) to a final working concentration of 5 µM; cell loading proceeds at 37 °C in a 5% CO₂ atmosphere for 30 min. The synthesis route converts the ethyl ester to the corresponding acyl hydrazide by reflux in ethanol with hydrazine monohydrate (5 eq, 8 h), then attaches a triphenylphosphonium cation via a hexamethylene spacer using HATU-mediated coupling in DMF/DIPEA. After preparative HPLC purification (C18, acetonitrile/water + 0.1% formic acid), the TPP-tagged probe displays a logP of 1.8 and fluorescence quantum yield of 0.22 (measured vs fluorescein in 0.1 M NaOH per IUPAC Technical Report 2004). In HeLa cells under oxidative stress induced by 100 µM menadione, confocal microscopy (excitation 488 nm, emission collected at 520–560 nm) reveals a 12‑fold fluorescence intensity increase over untreated controls, with colocalization analysis against MitoTracker Deep Red confirming Pearson’s coefficient r = 0.89. The terminal packaged product is a lyophilized kit format containing 50 µg of the probe, a DMSO vial, and assay buffer, shipped under dry ice with a validated ‑20 °C storage stability of 12 months per ICH Q1A(R2) thermocycling.If an Antiviral Nucleoside Requires a Bicyclic Heteroaromatic Base MoietyWithin the structure-guided design of a non-cleaved ribonucleoside analogue influenza polymerase inhibitor, the 4H-thieno[2,3-d]pyrrole-5-carboxylic acid ethyl ester serves as a pre‑functionalized purine isostere, furnishing the necessary hydrogen-bond donor–acceptor array to occupy the PB2 cap‑binding pocket. All synthetic steps supporting the preparation of a GLP toxicology batch must conform to ICH Q11 development and selection of starting materials, ICH M7 control of mutagenic impurities (with purge factor calculations for alkyl halide traces), FDA 21 CFR Part 312 IND safety reporting, and the EMA/CHMP/QWP/245074/2015 guideline on antiviral drug development. The glycosylation sequence begins with hydrolysis of the ester to the free acid (2 M NaOH, THF, 60 °C, 3 h), followed by Curtius rearrangement using diphenylphosphoryl azide (1.1 eq) and benzyl alcohol in toluene at 90 °C to install a Cbz‑protected amine at C5. The resulting carbamate is globally deprotected under hydrogenolytic conditions (1 atm H₂, 10% Pd/C, EtOAc, 25 °C) and the free amine is then subjected to a Vorbrüggen‑type silyl‑Hilbert‑Johnson glycosylation with 1‑O‑acetyl‑2,3,5‑tri‑O‑benzoyl‑β‑D‑ribofuranose. The molar ratio of the silylated heterocycle (pre‑treated with N,O‑bis(trimethylsilyl)acetamide, 2 eq) to the sugar acetyl donor is 1.0:1.3, with SnCl₄ (1.5 eq) in anhydrous 1,2‑dichloroethane at 25 °C for 16 h under argon. After quenching with ammonium chloride, benzoyl groups are removed with methanolic ammonia (7 N, 4 h, 25 °C) and the crude nucleoside is purified by flash chromatography (SiO₂, CH₂Cl₂/MeOH gradient) to ≥99.5% purity. Concentration and lyophilization from water yields the final research-grade compound, which demonstrates an EC₅₀ of 12 nM against an influenza A/WSN/33 virus replication assay in MDCK cells, with cytotoxicity CC₅₀ above 100 µM. The formulated drug substance is initially supplied as a micronized powder for oral suspension in phase‑0 microdosing studies, packed in HDPE bottles with desiccant under a nitrogen purge. |
Competitive Ethyl 4H-Thieno[2,3-D]Pyrrole-5-Carboxylate prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615651039172 or mail to sales9@bouling-chem.com.
We will respond to you as soon as possible.
Tel: +8615651039172
Email: sales9@bouling-chem.com
Flexible payment, competitive price, premium service - Inquire now!
| Test Parameter | Acceptance Criterion | Analytical Method | Reference Standard |
|---|---|---|---|
| Appearance | Off‑white to pale‑yellow solid | Visual inspection | In‑house STP‑APP‑001 |
| Identity by ¹H NMR | Spectrum matches reference; signals for thienyl H‑2 (δ 6.85 ppm), pyrrole NH (δ 11.2 ppm), ethyl CH₂ (δ 4.28 ppm), CH₃ (δ 1.32 ppm) | Bruker 400 MHz, DMSO‑d₆, against certified reference material | CRM lot ETPC‑R001 |
| Purity (HPLC) | ≥ 97.0% area | HPLC‑UV 254 nm as described | In‑house method TM‑HPLC‑021; system suitability per USP <621> |
| Water content | ≤ 0.5% w/w | Karl Fischer coulometric | USP <921> Method 1a |
| Residual solvents – ethyl acetate | ≤ 5000 ppm | Headspace GC‑FID, DB‑624 column | USP <467> Procedure A |
| Residual solvents – dichloromethane | ≤ 600 ppm | Headspace GC‑MS | USP <467> Procedure A |
| Heavy metals (as Pb) | ≤ 10 ppm | ICP‑MS after microwave digestion | USP <233> |
| Melting range (DSC) | 84–87 °C (onset) | DSC 10 °C min⁻¹, sealed Al pan | ASTM E794‑06 |